FDA Update
The U.S. Food and Drug Administration (FDA) has published a presentation on ongoing activities of the FDA. It also intends to show how changes in FDA regulations and actions could affect pharmaceutical industry's practice. The following tasks are covered:
- FDA mission
- Approval and actions
- Drug safety information
- Safe Use Initiative
- REMS/Medication Guides
- Patient Medication Information (PMI)
- Sentinel Initiative
- OTC News
- Recalls
- Drug shortages
- Supply chain integrity
Get more in the presentation "FDA Update".
Related GMP News
18.09.2024Lack of GMP Training and related Documentation: What Deviations can be found in FDA Warning Letters?
04.09.2024Switzerland: Changes for the Qualification of QPs (Responsible Person; RP in Switzerland)
04.09.2024Insufficient Root Cause Analysis leads to FDA Warning Letter
28.08.2024Switzerland to implement Measures to combat Shortages of Medicines
26.06.202410 points on how the FDA's CDER monitors the Quality of Medicinal Products
08.05.2024EMA Plans for the next three Years